Researchers at Wake Forest are utilizing stem cells from amniotic fluid as a universal cell source to regrow tissues. Injecting the stem cells right into a diseased kidney improved perform after 10 weeks—and repaired some blood vessel damage. Nterface Biologics Inc. from Canada has developed Endexo as a means to help make dialyzer membranes and bloodlines more biocompatible—and much less prone to clot. The technology, for which Fresenius holds an unique world-wide license, will scale back the necessity for heparin and other blood thinners. The VasQ, a nitinol cage placed round a model new artery and vein boosts the probabilities that a fistula will develop successfully. The FDA has granted breakthrough gadget designation to Laminate Medical’s new software.
Basecamp Bio is led by Yin...Read More